Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wesley Research Institute is a leading independent, non-profit medical research organization based in Brisbane, Australia, focused on improving patient outcomes through clinical innovation. Established in 1994 and closely integrated with UnitingCare Health hospitals, the institute serves as a critical link between laboratory research and clinical practice. It specializes in conducting Phase 1 through Phase 4 clinical trials across a broad spectrum of therapeutic areas, including neurology, oncology, cardiology, and gastroenterology. The institute is notably home to the COVID-19 Critical Care Consortium, a global study involving over 50 countries, and maintains a sophisticated Biobank to support genomic and proteomic research. By collaborating with global pharmaceutical companies and academic institutions, Wesley Research Institute facilitates the development of novel diagnostics and therapies for life-threatening conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wesley Research Institute.